Company: CAVA
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001628280-25-019936
Chunk: 28

Company: CAVA GROUP, INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 28
---
 of these 2023 grants provides helpful context for understanding how a significant portion of our NEOs’ compensation is at risk and tied to the achievement of the company’s financial performance as measured through our stock price appreciation, which reinforces a strong alignment between the compensation opportunities of our NEOs and the interests of our stockholders.

Mr. Schulman’s June 2023 IPO award (the “CEO IPO Award”) was granted in the form of 50% RSUs and 50% stock options. The CEO IPO Award vests in five equal annual installments commencing June 14, 2024, generally subject to Mr. Schulman’s continued employment through each applicable vesting date. The June 2023 IPO awards (the “NEO IPO Awards”) for Mses. Tolivar, Somers and Costanza and Mr. Xenohristos were also granted in an equal mix of stock options and RSUs. The NEO IPO Awards vest in four equal annual installments commencing June 14, 2024, generally subject to continued employment through each applicable vesting date. In addition to aligning the interests of our NEOs with those of our stockholders, the vesting periods applicable to the CEO IPO Award and NEO IPO Awards were intended to promote post-IPO retention and leadership stability among our NEOs.

#### CAVA Group, Inc.282025 Proxy Statement

#### Employment Agreements
In connection with our IPO, our Board of Directors approved an amended and restated employment agreement with Mr. Schulman (the “Amended and Restated CEO Agreement”), which was effective on June 20, 2023 and governs the terms and conditions of his employment with us. Under this agreement, Mr. Schulman will receive annual long-term incentive grants under our 2023 Equity Incentive Plan, with each award having a grant date value of $2,925,000 and denoted in a type or type(s) of award as determined by the Committee. The Amended and Restated CEO Agreement also provides Mr. Schulman with certain severance protections.

Mr. Xenohristos and Ms. Costanza also have entered into employment agreements with the Company that govern the terms and conditions of their employment and provide the executives with certain severance protections. Mses. Somers and Tolivar were subject to employment agreements that expired pursuant to their terms during 2024 and 2023, respectively. In the event of certain qualifying terminations of employment, each of our NEOs is afforded severance protection under